Bictegravir-Based Treatment Wins for HIV/HBV Co-Infections
(MedPage Today) -- MONTREAL -- For individuals infected by both HIV and hepatitis B virus (HBV), the choice of which virus-suppressing therapy to use can make a difference in outcomes, according to 48-week results of the phase III ALLIANCE results... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 4, 2022 Category: Gastroenterology Source Type: news
Ghana: Intensifying Awareness Creation About the Deadly Hepatitis 'B' Virus, a Move to Save Lives
[Ghanaian Times] Hepatitis B is the most common serious liver infection in the world. It is caused by the hepatitis B virus that attacks and injures the liver. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 29, 2022 Category: African Health Source Type: news
Africa: World Hepatitis Day - More Than 91 Million Africans Living With Disease - WHO
[Premium Times] Globally, the African region accounts for 70 per cent of the global Hepatitis B cases found among children younger than 5 years, with 4.5 million African children infected. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 29, 2022 Category: African Health Source Type: news
Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021
This report describes global progress towards the elimination of mother-to-child hepatitis B virus. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 28, 2022 Category: American Health Tags: Hepatitis B Hepatitis B Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news
Ghana: World Hepatitis Day, July 28 (1)
[Ghanaian Times] The burden of hepatitis B infection is highest in the WHO Western Pacific Region and the WHO African Region, where 116 million and 81 million people, respectively, are chronically infected. In 2019, hepatitis B resulted in an estimated 820 000 deaths, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer). Hepatitis B can be prevented by vaccines that are safe, available and effective. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 28, 2022 Category: African Health Source Type: news
Nigeria: World Hepatitis Day - Taming the Tide of Rising Hepatitis Cases in Nigeria
[Daily Trust] Nigeria is estimated to have a high burden of hepatitis, particularly hepatitis B and C. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 28, 2022 Category: African Health Source Type: news
Enhanced surveillance of childhood cases of hepatitis B and C in England
This protocol details the objectives and methods of collection for the surveillance of childhood cases of hepatitis B and hepatitis C in England. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 28, 2022 Category: Consumer Health News Source Type: news
Nigeria: 20 Million Nigerians Infected With Hepatitis B, C - Govt
[Daily Trust] Nearly 20 million Nigerians are infected with Hepatitis B or C, the Minister of Health, Osagie Ehanire, has said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 27, 2022 Category: African Health Source Type: news
Ghana: Hepatitis B,C Screening Takes Place Ahead of World Hepatitis Day Celebration
[Ghanaian Times] The Greater Accra Regional Hospital, Department of Public Health / Internal Medicine, in collaboration with Gaslidd Ghana and Roche has held a two-day Hepatitis B and C Screening as precursor to World Hepatitis Day schedule to take place on Thursday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 26, 2022 Category: African Health Source Type: news
Childhood hepatitis surge ‘probably linked to two common viruses’
Scientists say simultaneous infection with viruses may explain rise in cases, with 12 UK children requiring liver transplantsSimultaneous infection with two common viruses is thought to explain a recent surge inchildhood hepatitis cases, which has led to 12 UK children requiring liver transplants so far.Two research groups have detected high levels of adeno-associated virus 2 (AAV2) – a little-known virus not previously associated with human disease – in almost all of the affected British children they have tested. AAV2 is unable to replicate by itself but can do so in the presence of a second virus.Continue reading......
Source: Guardian Unlimited Science - July 25, 2022 Category: Science Authors: Linda Geddes Science correspondent Tags: Children's health Hepatitis B Hepatitis C Society Medical research Science Source Type: news
Lab Notes: FDA approves Incyte's vitiligo treatment; Neuronetics gets a 'big win'
A Bucks County biopharma firm has an update on its pursuit of a hepatitis B therapy. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 22, 2022 Category: Health Management Authors: John George Source Type: news
Relapse Patterns in Chronic Hep B After Halting Treatment
(MedPage Today) -- Chronic hepatitis B patients who discontinued tenofovir disoproxil fumarate (TDF, Viread) after achieving viral suppression had higher rates of clinical relapse compared to those who stopped entecavir, a global retrospective... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 21, 2022 Category: Gastroenterology Source Type: news
Peninsula biotech to cut 30 jobs as it shuts down one hepatitis B to focus on others
The company is cutting its first-generation hepatitis B virus inhibitor program but is prioritizing two other potential hep B therapies. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 20, 2022 Category: Health Management Authors: Ron Leuty Source Type: news
CDC Endorses Novavax COVID-19 Shot for Adults
U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax—a more traditional kind of vaccine, health officials said Tuesday.
Regulators authorized the nation’s first so-called protein vaccine against COVID-19 last week, but the final hurdle was a recommendation from the Centers for Disease Control and Prevention.
“If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time to join the millions of Americans who have been vaccinated,” Dr. Rochelle Walensky, CDC’s director, said in a s...
Source: TIME: Health - July 20, 2022 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Why You ’ ll Need to Get COVID-19 Boosters Again and Again
Several highly effective vaccines were developed at an unprecedented speed to combat the COVID-19 pandemic. During the phase 3 clinical trials, mRNA vaccines had vaccine efficacy of 94–95% in preventing symptomatic infections. After the rollout, real-world evidence showed that the mRNA vaccines provided ~90% effectiveness against infection. Then came the variants. The wave after wave of new variants, with ever-increasing transmissibility and capacity to escape existing immunity, challenge the ability of vaccines to prevent infection and transmission. The effectiveness of a primary series of mRNA vaccines (two doses) ...
Source: TIME: Health - July 19, 2022 Category: Consumer Health News Authors: Akiko Iwasaki and Albert Ko Tags: Uncategorized COVID-19 freelance Source Type: news
